Mossad chief Dagan’s corneas give sight back to 2 Israelis

Avraham Gian, 81, ‘amazed’ to discover that he has ‘a hero of Israel’ to thank for the return of his sight

Former Mossad chief Meir Dagan, May 2011. (photo credit: Kobi Gideon/Flash90)
Former Mossad chief Meir Dagan, May 2011. (photo credit: Kobi Gideon/Flash90)

Two people have regained their eyesight after receiving the corneas of the late former Mossad chief Meir Dagan, who died March 17 after a long battle with cancer.

Avraham Gian, 81, and an unnamed 70-year-old woman were the recipients of the corneas, the transparent layer that forms the front of the eye.

The operations were carried out at Tel Aviv’s Ichilov Hospital.

“I’m amazed to discover that the corneas of a hero of Israel like him were implanted in me,” Gian told Channel 10 Tuesday.

Avraham Gian (Channel 2 screenshot)
Avraham Gian (Channel 2 screenshot)

“We all owe this man, and now I most of all, because I can see because of him…. I hope to have my sight for years to come after many years of not being able to see a thing,” he said.

Gian’s wife Sarah told Channel 2, “Avraham is very pleased; his sight has returned after two very difficult years… It’s a different world for him.”

Deborah Sard, spokeswoman for Ichilov’s transplant center, said growing numbers of Israelis were signing commitments to donate organs after their deaths.

Dagan, a retired military general, served for 32 years as an Israel Defense Forces officer, reaching the rank of major general. He is credited with leading some of the IDF’s most daring missions, and served in the Six Day War, Yom Kippur War and First Lebanon War.

read more:
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure:
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.